Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03834961Phase 2Active Not Recruiting
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
Central Nervous System NeoplasmInfantile FibrosarcomaRecurrent Acute Leukemia+2 more
PrincipalinvestigatorStart date: 2019-10-25
NCT03213678Phase 2Completed
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more
PrincipalinvestigatorStart date: 2017-11-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Amar Gajjar, MD

St. Jude Children's Research Hospital

Related
10 trials

Shared therapeutic areas:

Central Nervous System NeoplasmsRhabdoid Tumor

Worked with same sponsors:

Children's Oncology GroupNational Cancer Institute (NCI)
Similarity Score2%

David Hui, MD

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Giselle Sholler, MD

Beat Childhood Cancer at Atrium Health

Related
10 trials

Shared therapeutic areas:

Refractory NeuroblastomaWilms Tumor
Similarity Score2%

Anthony El-Khoueiry, MD

University of Southern California

Related
6 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Sriram Yennu

M.D. Anderson Cancer Center

Related
12 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Recurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

David Hui

M.D. Anderson Cancer Center

Related
9 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Luhua (Michael) Wang

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Recurrent Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Wilms Tumor

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03834961Phase 2PrincipalInvestigator

Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia

Central Nervous System NeoplasmInfantile FibrosarcomaRecurrent Acute Leukemia+2 more
Active Not Recruiting
NCT03213678Phase 2PrincipalInvestigator

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more
Completed

All 2 trials loaded